Results 241 to 250 of about 97,023 (309)

Isocitrate Dehydrogenase Mutations in Cancer: From Bench to Bedside Applications

open access: yesMedComm, Volume 7, Issue 5, May 2026.
Mutant isocitrate dehydrogenase affects multiple cancer types. Alterations in IDH1 and IDH2 result in abnormal enzyme activity, leading to the overproduction of D‐2‐hydroxyglutarate (D‐2HG). This metabolite disrupts cellular metabolism and epigenetic regulation, driving cancer initiation, progression, and metastasis.
Yuhan Fang   +6 more
wiley   +1 more source

Combination therapy with tobevibart and elebsiran potently reduces hepatitis B virus surface antigen levels in preclinical <i>in vivo</i> models. [PDF]

open access: yesAntimicrob Agents Chemother
Noack J   +11 more
europepmc   +1 more source

HBV RNA at 6 months after nucleos(t)ide analogues treatment can predict antiviral efficacy in chronic hepatitis B patients. [PDF]

open access: yesBMC Gastroenterol
Xie Y   +14 more
europepmc   +1 more source

Distribution of domestic cat hepatitis B virus in cholangiocarcinoma and non-neoplastic liver tissue. [PDF]

open access: yesJ Vet Med Sci
Dosaka H   +9 more
europepmc   +1 more source

Generation of virus specific cytotoxic T cells in vitro [PDF]

open access: yes, 1979
Greber, D.   +2 more
core  

Xenotransplantation: principles and practice [PDF]

open access: yes, 1996
Fung, JJ   +3 more
core  

MAIT Cells in Liver Disease. [PDF]

open access: yesCells
Azad AI, Gutierrez F, Gores GJ.
europepmc   +1 more source

Home - About - Disclaimer - Privacy